Data as of Nov 26
| +0.01 / +0.26%|
The 2 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 11.25, with a high estimate of 12.00 and a low estimate of 10.50. The median estimate represents a +196.05% increase from the last price of 3.80.
The current consensus among 2 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.